Search

Pakistan has one of the worst maternal mortality ratios worldwide: 260-490 women die for every 100,000 live births in Pakistan. The Pakistan Liaison Group (PLG) was formed to work with and through the international office of the Royal College of Obstetricians and Gynaecologists (RCOG). It works with the RCOG representative committee in Pakistan to improve the health of women. It aims to contribute to improving maternal morbidity and mortality through strategies directed at improving the education and training of health professionals. In addition, the PLG aims to promote changes in the legislature to allow for the notification of maternal deaths so that accurate figures can be obtained, and so that health parameters can be accurately assessed and, in the long term, a confidential enquiry into maternal deaths can be initiated.

In mid-trimester amniocentesis (MTA), 12–15 ml of amniotic fluid is aspirated for cytogenetic analysis. When a similar volume of amniotic fluid is removed by early amniocentesis (EA), it represents a significant proportion of the total amniotic fluid volume in the first trimester. The fluid depletion, which may persist for 7 to 10 days, is considered to impair development of fetal lungs and extremities and, possibly, contribute towards procedure-related congenital abnormalities and miscarriages. By only removing 7 ml of amniotic fluid, we have demonstrated a total miscarriage rate (3·8 per cent) comparable with previous large studies (Table V), a low incidence of respiratory difficulties at birth (2·7 per cent) and a low incidence of fixed flexion deformities (1·6 per cent), at the expense of a small increase in the incidence of culture failure (2·2 per cent). © 1998 John Wiley & Sons, Ltd.

Pakistan has one of the worst maternal mortality ratios worldwide: 260-490 women die for every 100,000 live births in Pakistan. The Pakistan Liaison Group (PLG) was formed to work with and through the international office of the Royal College of Obstetricians and Gynaecologists (RCOG). It works with the RCOG representative committee in Pakistan to improve the health of women. It aims to contribute to improving maternal morbidity and mortality through strategies directed at improving the education and training of health professionals. In addition, the PLG aims to promote changes in the legislature to allow for the notification of maternal deaths so that accurate figures can be obtained, and so that health parameters can be accurately assessed and, in the long term, a confidential enquiry into maternal deaths can be initiated.

During a 1-year period, 662 pregnant women at 24–43 weeks' gestation were referred to the Department of Obstetrics and Gynaecology, at the Queens University Belfast, for fetal assessment because they were clinically suspected to be at high risk of perinatal complications. The results of our investigations were made available to the referring obstetricians who undertook the further management of the pregnancies. Subsequently six pregnancies resulted in perinatal deaths and 97 (14.7%) in the delivery of small-for-gestational-age infants. We restrospectively analyzed the data from ultrasonographic evaluation of the fetus and subjective and objective assessments of the amniotic fluid volume to determine their value in the prediction of adverse perinatal outcome. A fetal abdominal circumference < 10th centile for gestation or a subjectively reduced amniotic fluid volume identified 87 (90%) of small-for-gestational-age infants and five of the six perinatal deaths. When comparing the abdominal circumference and subjective liquor volume, both were sensitive in predicting delivery of a small-for-gestational-age fetus (sensitivity 86% vs. 53%, respectively) and perinatal death (sensitivity 50% vs. 83%, respectively). We suggest that, since assessments of these two factors are complementary in evaluating a high-risk pregnancy and can be measured in under 5 min, they now warrant consideration for screening in a prospective randomized trial in an unselected low-risk population. Copyright © 1993 International Society of Ultrasound in Obstetrics and Gynecology

The aim of this retrospective study is to assess the value of routine ultrasonography in the detection of renal abnormalities. Twenty-nine pregnancies (one set of twins) with suspected renal abnormalities (i.e. renal cystic spaces, oligohydramnios or hyperechoic kidneys) were delivered over a two year period (1.8.1987-31-7-1989) in a unit where 90% of pregnancies (6,562) were scanned routinely at 18-20 weeks gestation or later, if booking for confinement was delayed. In pregnancies with suspected anomalies prenatal ultrasound was performed monthly until 28 weeks and fortnightly until delivery. Non survivors [5] had histological or postmortem examination. Liveborn infants [25] had renal ultrasonography in the neonatal period and paediatric follow-up if abnormal. Sixteen (53%) of the 30 cases (one set of twins) suspected of renal abnormalities by routine prenatal ultrasonography had renal anomalies confirmed postnatally. Five women were non survivors, all of which had associated anomalies. In the eleven survivors the diagnoses were pelvi-ureteric junction obstruction [6], renal dysplasia [2], vesicoureteric reflux [2] and suspected ureterocele [1]. Fourteen infants with pelvicalyceal dilatation had normal postnatal renal ultrasound. Although abnormal prenatal renal ultrasound is a useful indicator of postnatal disease and aids decisions on the management of pregnancy, further large collaborative studies with extended paediatric follow-up are required to assess the significance of pelvicalyceal dilatation.

AIMS—To quantify the incidence of ventricular septal defect in "low-risk" neonates; and to define any associated risk factors. METHODS—One hundred and seventy three patients with ventricular septal defects from a scanned population of 3971 clinically normal neonates were compared with scanned controls, considered to be clinically normal. A subset of the group with defects was compared with normal infants delivered over the same period, to identify any seasonal variation. RESULTS—Ventricular septal defects were detected in 4.36 % of the "scanned" group (173 out of 3971). Ten had perimembranous defects and the remainder apical or muscular lesions. Eleven neonates had multiple defects. The incidence of ventricular septal defect was independent of most tested risk factors. There were significantly more girls in the group with defects compared with the controls (p = 0.004). The defects group also contained fewer infants born during summer months (p = 0.04). CONCLUSIONS—The incidence of ventricular septal defects was much higher than might be expected, given that "high risk infants" were excluded. The observations that gender and season of birth affect the rate suggest that both genetic and environmental factors may be involved in the aetiology.

Early amniocentesis from 9 to 14 weeks' gestation provides a safe and accurate method of prenatal diagnosis of cytogenetic and biochemical disorders. There was a 100 per cent success rate in culturing the amniotic cells from 222 samples obtained between 9 and 14 weeks' gestation. Follow-up of the patients to delivery revealed an abortion rate of 1.4 per cent. Among the 207 live- and stillborn infants, only one had a congenital abnormality (bilateral talipes equino-varus) and no infant had respiratory distress syndrome or pneumonia. Eleven pregnancies were terminated following the detection of a chromosomal, biochemical, or congenital abnormality (5.0 per cent). However, before the procedure of early amniocentesis becomes routine clinical practice, it requires appraisal by a randomized clinical trial.

The effect on pregnancy outcome of transplacental needle insertion was studied in 401 consecutive women attending for early amniocentesis between 10 and 14 completed weeks of pregnancy. Transplacental early amniocentesis was associated with a significantly higher incidence (P0.001) of blood-stained amniotic fluid taps but a lower incidence (not significant; P0.05) of pregnancy loss and miscarriages. Women in the nontransplacental early amniocentesis group had a significantly higher (P0.01) incidence of late procedure-related antenatal complications, such as preterm rupture of membranes or preterm labour. Our study showed that transplacental early amniocentesis is a safe procedure; contrary to present recommendations, the study also showed that avoiding the placenta during early amniocentesis is an unnecessary practice.

A 31-year-old woman with 7 weeks’ amenorrhoea presented to casualty with 2 hours history of left iliac fossa pain and vaginal brownish staining. There was no history of shoulder tip pain, urinary or bowel symptoms. A urine beta hCG (Clearview) test was positive. Due to a past history of anovulatory cycles, she had been prescribed clomiphene from day 2 to day 5 of her menstrual cycle. Abdominal examination revealed localized tenderness on gentle palpation in the left iliac fossa associated with guarding, but no rebound tenderness. Pelvic examination revealed a closed cervical os, marked cervical tenderness and a normal sized anteverted uterus with left forniceal fullness and tenderness. Vaginal ultrasound revealed a pseudosac measuring 1 cm in diameter in the uterus. A mass was seen in the left adnexa with two gestational sacs within it. The ® rst sac contained a distinctive fetal pole with a crown rump length (CRL) equivalent to a 8 weeks size fetus and the fetal heart was present. The second sac measured 1´8 cm by 1´4 cm and no fetal pole was

Spatone Iron-Plus is a naturally occurring mineral water from Trefriw Wells Spa in Conwy County, North Wales, UK. It contains approximately 0.20 mg of iron per millilitre as ferrous sulphate and has been shown to provide iron in a highly bio-available form. A 24 ml sachet contains approximately 5 mg of iron. Iron deficiency is common in the obstetric population. However, compliance with traditional iron supplements is poor because of gastrointestinal side-effects. We designed a randomized, double-blind, placebo-controlled trial. A total of 102 low-risk antenatal patients, who were noncompliant with routinely prescribed ferrous sulphate tablets, were randomized to receive 48 ml of Spatone water or placebo. The study was conducted between 22 and 28 weeks gestation. Primary outcome measures were compliance, gastrointestinal side-effects and changes in ferritin levels during the trial period. Compliance in the intervention group was 57% compared with 67% in the control group, P = 0.22. Dyspepsia scores, as determined by a recognized and well-validated questionnaire, did not differ between the two groups. During the trial period, mean ferritin levels fell by 24% in the Spatone Iron-Plus group compared with a mean fall of 51% in ferritin levels among the control group, P = 0.016.

The objective of this study was to evaluate routine obstetric ultrasound in detecting fetal structural anomalies and the impact of changing clinical practice on success rates. A retrospective study of routine ultrasound in a population of 6,869 pregnancies was performed during 1985-86 (phase 1) to establish efficacy of ultrasound in the detection of fetal anomalies. Changes in ultrasound practice comprised timing, personnel and technique of fetal examination. After alterations in practice, a prospective study of 6,969 pregnancies during 1987-89 (phase 2) was performed. All abnormal fetuses (cases) were assessed in both studies. Random samples of normal infants (controls) were chosen from both populations to establish specificity. In 83 cases in phase 1,116 anomalies were diagnosed postnatally of which 11 were suspected by routine prenatal ultrasound at24 weeks (sensitivity 9%, 95% C.I. 4-15). In 72 cases in phase 2, 89 anomalies were identified postnatally of which 27 were suspected by routine prenatal ultrasound at24 weeks (sensitivity 30%, 95% C.I. 21-41). The change in sensitivity was statistically significant (p = 0.0003). Of the 382 control infants randomly selected in phase 1, false abnormal scans were not identified (specificity 100%, 95% C.I. 99-100). Of the 367 control infants in phase 2, 12 false abnormal scans were identified (specificity 96.7%, 95% C.I. 95-99). The decrease in specificity was statistically significant (p = 0.0013). The detection of urorenal and to a lesser degree central nervous system anomalies showed most improvement between the two phases. The alterations to routine ultrasound practice in timing, personnel and technique have significantly improved the detection of all fetal structural anomalies but at the cost of a small but significant loss of specificity.

To demonstrate similarities and differences between the various instruments used by clinical trialists for measurement of premenstrual syndrome to encourage development of consensus of measurement to aid future research.Computer and manual searches of all trials of drugs used for premenstrual syndrome supplemented by retrieval of all questionnaires and scales cited. Letters were sent to the main manufacturers to identify trials not in the public domain.Number of scales in current use for classifying premenstrual syndrome; the symptoms included within them; their organisation of symptoms into clusters; the numerical values used in the scaling; the most frequently used items; and the extent of overlap in the criteria used.Three hundred and fifty clinical trials of 115 different drugs were identified. The most common symptoms or signs used in the scales were (frequency in square brackets) irritability [44], headache or migraine [40], depression [37], tearfulness [34], tension [31], anxiety [31], breast tenderness [31], mood swings or lability [30], back pain [30], weight gain [29], abdominal bloating [28], lack of concentration [28], food craving [28], and increased appetite [26]. Sixty-five different questionnaires or scales were used to classify premenstrual syndrome and for assessing entry eligibility and treatment outcomes; of these 65, 47 included sufficient details for a formal analysis and 18 scales grouped the symptoms or items into clusters or subgroups.There is wide diversity in the scales used for assessing entry eligibility and treatment outcomes in premenstrual syndrome. This makes comparative evaluation of possible treatments extremely complex and difficult. It is recommended that authorities and organisations involved in conducting trials of treatments for premenstrual syndrome develop a consensus statement about the best instrument to be used. Regulatory authorities could perhaps provide guidance to which scales they would accept when clinical trials of drugs for premenstrual syndrome are submitted to them for assessment. This would ensure that industry-sponsored trials provide objective data. Consensus is required given the poor performance of most current treatments of premenstrual syndrome.

During a 1-year period, 662 pregnant women at 24-43 weeks' gestation were referred to the Department of Obstetrics and Gynaecology, at the Queens University Belfast, for fetal assessment because they were clinically suspected to be at high risk of perinatal complications. The results of our investigations were made available to the referring obstetricians who undertook the further management of the pregnancies. Subsequently six pregnancies resulted in perinatal deaths and 97 (14.7%) in the delivery of small-for-gestational-age infants. We restrospectively analyzed the data from ultrasonographic evaluation of the fetus and subjective and objective assessments of the amniotic fluid volume to determine their value in the prediction of adverse perinatal outcome. A fetal abdominal circumference10th centile for gestation or a subjectively reduced amniotic fluid volume identified 87 (90%) of small-for-gestational-age infants and five of the six perinatal deaths. When comparing the abdominal circumference and subjective liquor volume, both were sensitive in predicting delivery of a small-for-gestational-age fetus (sensitivity 86% vs. 53%, respectively) and perinatal death (sensitivity 50% vs. 83%, respectively). We suggest that, since assessments of these two factors are complementary in evaluating a high-risk pregnancy and can be measured in under 5 min, they now warrant consideration for screening in a prospective randomized trial in an unselected low-risk population.

Purpose: To examine fetal breathing movements in fetuses with congenital diaphragmatic hernia and compare this to unaffected fetuses and with their outcome after birth. Methods: Twenty women with normal singleton pregnancies and four cases of congenital diaphragmatic hernia were studied. All fetuses were observed for 60 min at 36 weeks of gestation. Fetal breathing movements were observed by scan taking a cross-sectional view across the abdomen. The scan was recorded and breathing movements analyzed off-line. All sessions occurred at the same time of the day and two hours after a light meal. No patients were cigarette smokers. Bouts of fetal breathing activity were defined as the length in seconds of each series of successive individual breathing movements bracketed by periods of apnea. The absence of fetal breathing movements for more than 3 s was called the apnea period. Total duration of breathing was the sum of all bouts. Results: The normal fetuses exhibited a breath to breath interval of 1.3 s and displayed breathing movements for around 30–35% of the observation period. Of the four fetuses with congenital diaphragmatic hernia, three died during the neonatal period due to lung hypoplasia, one survived following surgical repair. All four fetuses exhibited a similar breath to breath interval as unaffected fetuses but the three fetuses who died spent 80% (range 70–90%) of the time breathing whereas the fetus that survived spent 32% of its time breathing. Increased yawning was also observed in the fetuses who died. Conclusions: It has been speculated that the inhibition of fetal breathing movements may result in pulmonary hypoplasia, yet fetuses with lung hypoplasia spend more time breathing than those without lung hypoplasia. The relationship between breathing movements and lung development requires further study. Breathing movements may provide important information on fetal health and outcome.

The effect of fetal breathing movements (FBM) of maternal breathing of 50% oxygen was examined. The procedure caused a two-fold rise in maternal arterial Po2 and did not alter FBM in normal pregnancy. In pregnancy complicated by intrauterine growth retardation (IUGR) a substantial increase in the incidence of FBM was recorded during hyperoxia (control 29.8 +/- 3.9%, hyperoxia 68.2 +/- 3.6). No such change was observed in pregnancies where IUGR was suspected but not proven at delivery.

The rate and regularity of fetal breathing movements (FBM) were determined in 14 women with uncomplicated singleton pregnancies, eight of whom were between 30 and 33 weeks gestation and six between 37 and 40 weeks gestation. Similar observations were made in 19 women with pregnancies complicated by severe intrauterine growth retardation, 11 of whom were between 30 and 33 weeks and eight between 37 and 40 weeks. In normal pregnancy recordings of breath-to-breath intervals showed that FBM became more regular with advancing gestational age, and the rate [breaths/min, mean (SEM)] slowed from 57.2 (1.3) at 30-33 weeks to 47.9 (0.8) at 37-40 weeks. FBM in the growth-retarded group were regular at each gestation studied and the rate was even slower than in the normal group at term, being 41.9 (1.2) at 30-33 weeks and 41.1 (1.0) at 37-40 weeks. Hyperoxia and hypercapnia appeared to have no consistent effect on fetal breathing rate. Fasting for greater than 12 h considerably reduced the rate of FBM in the normal fetus but only marginally so in those with growth retardation. It is concluded that the pattern of FBM provides more information about the fetus than the amount of time spent breathing, particularly when growth is retarded.

Fetal breathing movements have been studied in conjunction with features of anatomical and biochemical development of the lung at birth in fetuses with congenital abnormalities affecting the respiratory system. Total absence of fetal breathing movements or abnormal fetal breathing movements were associated with lung hypoplasia and failure of normal surfactant release into saline extracts of lung fluid. Surfactant synthesis was demonstrated regardless of the presence or absence of fetal breathing movements. The study supports the hypothesis that normal fetal breathing movements are important for fetal lung development and suggests that surfactant synthesis and its release are independent. The latter process may be dependent upon fetal breathing movements while the former is not.

The structure of the capillary plexus in the gas exchange zone in the lungs of five neonates was investigated by electron microscopy and cytochemical techniques. The results show that the capillaries associated with the terminal respiratory saccules are narrow and that they generally possess two to three endothelial cells per cross section. "Seamless" and protoplasmic capillaries were not observed. A capillary plexus was located on either side of each intersaccular septum and the mesh size of this plexus was relatively large. The gas diffusion pathway in the neonatal lung was found to be very short (mean 1.84 micron). It is suggested that the layer of periodate reactive material lining the luminal surfaces of the capillary endothelial cells may have important functions in vivo.

To assess the usefulness of continuous wave Doppler ultrasonography as an antenatal screening tool for the detection of intrauterine growth retardation and fetal compromise 2097 singleton pregnancies were studied. Umbilical artery velocity waveforms were obtained at 28, 34, and 38 weeks of gestation, from which the pulsatility index, A/B ratio, and resistance parameter were calculated. No abnormal features or indices of neonatal outcome were adequately predicted. The most sensitive index for being delivered of a growth retarded infant (less than 5th centile birth weight for gestation) was an A/B ratio at 34 weeks (sensitivity 40%, specificity 84%). Other measures that show poor neonatal nutritional state (ponderal index, skinfold thickness, and ratio of mid-arm circumference to head circumference) were even less well predicted. Acute and chronic hypoxia as determined by Apgar score, pH in blood from the cord artery, and packed cell volume correlated poorly with umbilical artery waveform indices, and there was no obvious difference between the indices of those who subsequently required operative or instrumental delivery for fetal distress and those requiring no intervention. There were three unexplained stillbirths in the series, in each of which the fetus had shown waveform patterns that suggested increased peripheral resistance, though the technique did not appear to be useful for predicting the time of subsequent death. Screening for small for dates babies in a three stage programme was of no value regardless of the threshold or index chosen. Obstetricians should resist the temptation to introduce screening with Doppler ultrasonography until its proper role has been determined.

Between 1970 and 1983, 519 pregnancies in 405 women with heart disease were managed at the Royal Maternity Hospital, Belfast, Northern Ireland, a rate of 1.3 per 100 deliveries. In 312 (60%) the heart disease was of rheumatic origin, in 161 (31%) congenital, and the remaining 46 (9%) were a miscellaneous group that included arrhythmias, ischaemic heart disease and cardiomyopathies. The New York Heart Association (NHYA) grading was no greater than 1-2 in 445 (86%) pregnancies antenatally. Three maternal deaths occurred, all in the group whose antenatal NYHA grade was 3-4. Heart failure was present in 96 (18%) pregnancies antenatally, and six others developed failure during labour or in the puerperium. Prophylactic antibiotics were not used routinely and infective endocarditis did not occur. The perinatal mortality rate was 19/1000, and the rate of congenital malformations was not raised in the reviewed group.